Skip to content 
The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified. more
| Time Frame | PSIL | S&P500 |
|---|---|---|
| 1-Week Return | 1.72% | 0.47% |
| 1-Month Return | 2.92% | 0.37% |
| 3-Month Return | 23.03% | 12% |
| 6-Month Return | 10.08% | 9.55% |
| 1-Year Return | 33.1% | 24.06% |
| 3-Year Return | 3.03% | 68.93% |
| 5-Year Return | -79.87% | 78% |
| Stock name | Ticker | Weight |
|---|---|---|
 COMPASS PATHWAYS PLC | CMPS | 12.04% |
 ATAIBECKLEY INC | ATAI | 9.58% |
 Definium Therapeutics, Inc | DFTX | 8.88% |
 RELMADA THERAPEUTICS INC | RLMD | 7.89% |
 NRX PHARMACEUTICALS INC | NRXP | 7.16% |
 GH RESEARCH PLC | GHRS | 4.96% |
 ALKERMES PLC | ALKS | 4.59% |
 NEUROCRINE BIOSCIENCES INC | NBIX | 4.39% |
 ALTO NEUROSCIENCE INC | ANRO | 4.23% |
 CYBIN INC | HELP | 4.01% |
 ABBVIE INC | ABBV | 3.99% |
 BLACKROCK TREASURY TRUST INSTL 62 | . | 3.65% |
 JOHNSON & JOHNSON | JNJ | 3.6% |
 BRIGHT MINDS BIOSCIENCES INC | DRUG | 3.59% |
 SUPERNUS PHARMACEUTICALS INC | SUPN | 3.28% |
 NEUPHORIA THERAPEUTICS INC | NEUP | 2.91% |
 NEURONETICS INC | STIM | 2.44% |
 QUANTUM BIOPHARMA-B SUB VOT | QNTM | 1.95% |
| SILO PHARMA INC | . | 1.24% |
 OPTIMI HEALTH CORP | OPTH | 1.23% |
 PASITHEA THERAPEUTICS CORP | KTTA | 1.18% |
 PSYENCE BIOMEDICAL LTD | PBM | 1.03% |
 VISTAGEN THERAPEUTICS INC | VTGN | 0.79% |
 INCANNEX HEALTHCARE INC | IXHL | 0.58% |
 IGC PHARMA INC | IGC | 0.5% |
 NUMINUS WELLNESS INC | NUMIF | 0.45% |
 ENVERIC BIOSCIENCES INC | ENVB | 0.12% |
| CLEARMIND MEDICINE INC | . | 0.01% |
| SAGE THERAPEUTICS CVR | . | 0% |
| UNBUZZD WELLNESS INC | . | 0% |
| QUANTUM BIOPHARMA LTD | . | 0% |
| CASH | . | -0.25% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
AdvisorShares Psychedelics ETF (PSIL) share price today is $20.0904.
Yes, Indians can buy shares of AdvisorShares Psychedelics ETF (PSIL) on Vested. To buy PSIL from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of AdvisorShares Psychedelics ETF (PSIL) on Vested. You can start investing in AdvisorShares Psychedelics ETF (PSIL) with a minimum investment of $1.
The 52-week high price of AdvisorShares Psychedelics ETF (PSIL) is $22.49. The 52-week low price of AdvisorShares Psychedelics ETF (PSIL) is $12.17.
The stock symbol (or ticker) of AdvisorShares Psychedelics ETF is PSIL.
Yes, you can setup SIP in AdvisorShares Psychedelics ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of PSIL on the Vested app.
The expense ratio of AdvisorShares Psychedelics ETF (PSIL) is 0.99%.
Link copied 
